Two of the Most Oversold Drug Stocks to Own Now

Pipette Dropping Stem Cell Research Liquid

Never feel like you must buy every recommendation that we issue in this free letter.

We’re simply bringing ideas to your attention that we believe hold immense opportunity for the short- and long-term.  For example, drug stocks took an incredible hit in recent weeks.  However, we believe the sell-offs are greatly overdone, leaving us with incredible opportunities.

Here are two of our favorites in the sector.

Opportunity No. 1 – Merck (MRK)

Merck (MRK) is severely oversold at bottom o...

Register Now

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Already a member? Login below, or click here to register now for free.